<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03044210</url>
  </required_header>
  <id_info>
    <org_study_id>6372</org_study_id>
    <nct_id>NCT03044210</nct_id>
  </id_info>
  <brief_title>Metabolic Study of Cockayne Syndrome</brief_title>
  <acronym>METABO-CS</acronym>
  <official_title>Metabolic Study of Cockayne Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cockayne syndrome (CS) is related to defective DNA transcription and/or repair and belongs to
      the family of Nucleotide Excision Repair. It is an autosomal recessive multisystemic disorder
      characterized by mental retardation, microcephaly, severe growth failure with lipoatrophia,
      sensorial impairment, cutaneous photosensitivity, dental decay, enophtalmios. The disease is
      progressive causing severe impairments but there's currently no therapeutics for the disease.

      Growth failure, feeding difficulties and lipoatrophia are prognostic keys of CS but
      physiopathology is unknown.

      According to preliminary assays, our goal is to test the hypothesis that cachexia is due to
      hypometabolism. We also want to test the potential link between this basal metabolism
      modification and mitochondrial dysfunction and somatotrope axis, and correlation between the
      basal metabolism degree and global severity of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rest energetic cost measured by indirect calorimetry compared to calculated Black equation</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rest energetic cost measured by indirect calorimetry compared to calculated theorical equations</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal axis evaluation and mitochondrial activity measured by level of hormones and lactates/pyruvates in blood</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory quotient measured by indirect calorimetry</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass and lean mass measured by impedancemetry</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Cockayne Syndrome</condition>
  <arm_group>
    <arm_group_label>Cockayne patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interventions performed:
blood sample
urinary collection
metabolic evaluation
clinical evaluation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interventions performed:
urinary collection
metabolic evaluation
clinical evaluation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Metabolic evaluation</intervention_name>
    <description>diet assessment
biological evaluation
clinical evaluation
metabolic evaluation (calorimetry)</description>
    <arm_group_label>Cockayne patients</arm_group_label>
    <arm_group_label>Control subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Cockayne patients:

        Inclusion criteria :

          -  Male and female with cockayne syndrome

          -  Age&gt;6 months

        Exclusion criteria:

          -  Intercurrent diseases

          -  Subject in period of exclusion

          -  Pregnancy and breastfeeding

        Control subjects :

        Inclusion criteria :

          -  Sister or brother of Cockayne patients

          -  Age&gt;6 months

        Exclusion criteria:

          -  Intercurrent diseases

          -  Subject in periods of exclusion

          -  Pregnancy and breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Aude SPITZ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HÃ´pitauc Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie-Aude SPITZ, MD</last_name>
    <phone>03 88 12 77 55</phone>
    <phone_ext>+33</phone_ext>
    <email>marie-aude.spitz@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincent LAUGEL, MD, PhD</last_name>
    <phone>0388128498</phone>
    <phone_ext>+33</phone_ext>
    <email>vincent.laugel@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam DURAND</last_name>
      <phone>0388128736</phone>
      <phone_ext>+33</phone_ext>
      <email>myriam.durand@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-Aude SPITZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent LAUGEL, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2017</study_first_submitted>
  <study_first_submitted_qc>February 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2017</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rest energetic cost measured by indirect calorimetry</keyword>
  <keyword>Hormonal axis</keyword>
  <keyword>Mitochondrial oxidative phosphorylation</keyword>
  <keyword>Basal metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cockayne Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

